Inactive Instrument
Auspex Pharmaceuticals Inc Share Price
Stocks
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 22/04/15 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 22/04/15 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sep Sarshar
BRD | Director/Board Member | 59 | 31/08/2009 |
Rod Ferguson
BRD | Director/Board Member | 69 | 31/12/2012 |
Alex Zisson
BRD | Director/Board Member | 56 | 16/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| +0.46% | -0.97% | +23.51% | +79.34% | 58.81B | |
| +0.17% | +0.35% | +6.85% | +34.55% | 48.45B | |
| +0.50% | -2.14% | +331.33% | +702.20% | 42.84B | |
| -0.72% | -3.99% | +28.50% | +29.94% | 42.79B | |
| +0.34% | -0.52% | +6.56% | +109.35% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| -0.50% | -3.10% | -10.19% | -14.35% | 24.05B | |
| Average | +0.25% | -0.25% | +53.35% | +123.79% | 43.81B | |
| Weighted average by Cap. | +0.69% | -0.50% | +56.27% | +130.20% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
